Registered Nurse in Hewlett, NY Accepting Medicare
9 Registered Nurse nurses found. Showing 1 - 9
 Laurie Susan Avchen, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1395 Sturl Ave, Hewlett, NY 11557 Phone: 516-680-6463 |
 Mr. Rodel Villarosa Placino, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 343 Hewlett Pkwy, Hewlett, NY 11557 Phone: 646-506-5504 |
Yelizaveta Kalendareva, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 327 Franklin Ave, Hewlett, NY 11557 Phone: 917-699-1764 |
Lendsa Guillaume, Registered Nurse Medicare: Medicare Enrolled Practice Location: 1258 Westervelt Pl, Hewlett, NY 11557 Phone: 516-250-3266 Fax: 516-250-3266 |
Tuval Newman, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1615 Nelson Ct, Hewlett, NY 11557 Phone: 347-752-2997 |
Patricia N Sideri, R.N Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Jackson Pl, Hewlett, NY 11557 Phone: 516-569-5436 Fax: 516-569-5436 |
Sharon Lane, Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 30 Sheridan Ave, Hewlett, NY 11557 Phone: 917-407-2325 |
Jane Deriquito, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 E Rockaway Rd, Hewlett, NY 11557 Phone: 516-791-3404 |
Sharon Breslin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 22 Frost Ln, Hewlett, NY 11557 Phone: 516-658-1923 |
News Archive
Ipsen receives marketing authorization in France for its 6-month sustained-release formulation of Decapeptyl
Ipsen, an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de Sécurité Sanitaire des Produits de Santé, AFSSAPS) have today granted the marketing authorization to the 6-month sustained-release formulation of Decapeptyl® (triptorelin embonate 22.5 mg) for the treatment of locally advanced and metastatic prostate cancer.
A road map to safer pain control, cost savings during colonoscopies
At a time when several U.S. health insurers have discontinued payment for use of the sedative propofol during most screening colonoscopies, physicians at the University of Pennsylvania School of Medicine have discovered that an alternative way to administer the drug could both save millions of health care dollars and provide a safer way to deliver optimal pain relief.
Curcumin, cancer-inhibiting peptides show promise in slowing progression of mesothelioma
A common Asian spice and cancer-hampering molecules show promise in slowing the progression of mesothelioma, a cancer of the lung's lining often linked to asbestos. Scientists from Case Western Reserve University and the Georg-Speyer-Haus in Frankfurt, Germany, demonstrate that application of curcumin, a derivative of the spice turmeric, and cancer-inhibiting peptides increase levels of a protein inhibitor known to combat the progression of this cancer.
Findings could help develop new ways to predict risks of tobacco-associated cancers
Believe it or not, while researchers have explored which genes are mutated in each type of tobacco-associated cancer, until now no one had thought to look across these types for common genes that might predict patient outcomes. Results presented at the AACR Annual Meeting 2013 show that in lung and bladder cancers, genes related to the regulation of the cell cycle are associated with poor patient outcomes.
IN.PACT drug-eluting balloons show promising results for superficial femoral artery disease treatment
Advancing research on drug-eluting balloons for the treatment of coronary and peripheral artery disease, Medtronic, Inc., today announced the latest results from the IN.PACT drug-eluting balloon (DEB) clinical program presented last week at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference.
› Verified 7 days ago